PERCEPTIVE ADVISORS LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$1.4T
Holdings
192
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (192 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NBIXNEUROCRINE BIOSCIENCES | 3,316,523 | $128.3B | 9.13% | |
| 2 | —TESARO | 687,993 | $92.5B | 6.58% | |
| 3 | AM6AMICUS THERAPEUTICS | 17,296,672 | $86.0B | 6.12% | |
| 4 | SRPTSAREPTA THERAPEUTICS | 2,769,829 | $76.0B | 5.41% | |
| 5 | —VERSARTIS | 4,153,685 | $61.9B | 4.40% | |
| 6 | —RETROPHIN | 2,687,412 | $50.9B | 3.62% | |
| 7 | —NXSTAGE MEDICAL | 1,927,989 | $50.5B | 3.60% | |
| 8 | XNCRXENCOR | 1,785,018 | $47.0B | 3.34% | |
| 9 | GBTUSDGLOBAL BLOOD THERAPEUTICS | 3,128,978 | $45.2B | 3.22% | |
| 10 | EGRXEAGLE PHARMACEUTICALS | 498,198 | $39.5B | 2.81% | |
| 11 | ACRSACLARIS THERAPEUTICS | 1,260,847 | $34.2B | 2.44% | |
| 12 | ARDXARDELYX | 1,836,196 | $26.1B | 1.86% | |
| 13 | —LION BIOTECHNOLOGIES INC | 3,567,553 | $24.8B | 1.76% | |
| 14 | RGNXREGENXBIO | 1,282,286 | $23.8B | 1.69% | |
| 15 | —COLUCID PHARMACEUTICALS | 641,364 | $23.3B | 1.66% | |
| 16 | —LA JOLLA PHARMACEUTICAL | 1,319,274 | $23.1B | 1.65% | |
| 17 | —AVEXIS | 473,531 | $22.6B | 1.61% | |
| 18 | —DBV TECHNOLOGIES ADR REPRESENTING 0.5 | 610,643 | $21.5B | 1.53% | |
| 19 | GLPGGALAPAGOS ADR REPRESENTING | 304,531 | $20.6B | 1.47% | |
| 20 | VAC2USDVBI VACCINES | 6,533,435 | $20.3B | 1.44% | |
| 21 | WVEWAVE LIFE SCIENCES | 665,198 | $18.1B | 1.29% | |
| 22 | BSFAANI PHARMACEUTICALS | 267,100 | $16.2B | 1.15% | |
| 23 | XLRNACCELERON PHARMA | 619,987 | $15.8B | 1.13% | |
| 24 | —FOAMIX PHARMACEUTICALS | 1,322,994 | $14.7B | 1.05% | |
| 25 | AVDLAVADEL PHARMACEUTICALS | 1,388,240 | $14.4B | 1.03% | |
| 26 | —ACELRX PHARMACEUTICALS | 5,408,728 | $14.1B | 1.00% | |
| 27 | —QUOTIENT | 2,854,486 | $13.8B | 0.98% | |
| 28 | —ACORDA THERAPEUTICS | 720,000 | $13.5B | 0.96% | |
| 29 | —ZYNERBA PHARMACEUTICALS | 842,128 | $13.1B | 0.93% | |
| 30 | —KADMON | 2,209,657 | $11.8B | 0.84% | |
| 31 | IRTCIRHYTHM TECHNOLOGIES | 352,241 | $10.6B | 0.75% | |
| 32 | ALDXALDEYRA THERAPEUTICS | 1,940,458 | $10.4B | 0.74% | |
| 33 | CTMXCYTOMX THERAPEUTICS | 923,763 | $10.2B | 0.72% | |
| 34 | —RADIUS HEALTH | 263,872 | $10.0B | 0.71% | |
| 35 | —DERMIRA | 325,583 | $9.9B | 0.70% | |
| 36 | CRBPEURCORBUS PHARMACEUTICALS HOLDINGS INC | 1,132,684 | $9.6B | 0.68% | |
| 37 | NERVGBPMINERVA NEUROSCIENCES INC | 810,537 | $9.5B | 0.68% | |
| 38 | —ZOGENIX | 752,999 | $9.1B | 0.65% | |
| 39 | —ANI PHARMACEUTICALS INC 01DEC19 3.0PCT | 7,500,000 | $8.7B | 0.62% | |
| 40 | ASMBASSEMBLY BIOSCIENCES | 714,354 | $8.7B | 0.62% | |
| 41 | BCRXBIOCRYST PHARMACEUTICALS | 1,330,240 | $8.4B | 0.60% | |
| 42 | —PFENEX | 914,376 | $8.3B | 0.59% | |
| 43 | —FIVE PRIME THERAPEUTICS | 163,255 | $8.2B | 0.58% | |
| 44 | —MYOKARDIA | 624,694 | $8.1B | 0.58% | |
| 45 | —CIDARA THERAPEUTICS | 773,369 | $8.0B | 0.57% | |
| 46 | —ALDER BIOPHARMACEUTICALS | 384,169 | $8.0B | 0.57% | |
| 47 | 2L9BLUEPRINT MEDICINES | 273,820 | $7.7B | 0.55% | |
| 48 | CLVSEURCLOVIS ONCOLOGY | 167,754 | $7.5B | 0.53% | |
| 49 | QUREUNIQURE | 1,265,963 | $7.1B | 0.50% | |
| 50 | —ANTARES PHARMA | 2,917,253 | $6.8B | 0.48% | |
| 51 | CLSDUSDCLEARSIDE BIOMEDICAL | 712,062 | $6.4B | 0.45% | |
| 52 | VRTXVERTEX PHARMACEUTICALS | 85,509 | $6.3B | 0.45% | |
| 53 | —NEPTUNE TECHNOLOGIES AND BIORESOURCES | 6,519,634 | $6.0B | 0.43% | |
| 54 | —FORWARD PHARMA ADR REPRESENTING 1 | 394,241 | $5.9B | 0.42% | |
| 55 | XENEXENON PHARMACEUTICALS | 740,272 | $5.7B | 0.41% | |
| 56 | JAZZJAZZ PHARMACEUTICALS | 52,000 | $5.7B | 0.40% | |
| 57 | AKBAAKEBIA THERAPEUTICS | 537,256 | $5.6B | 0.40% | |
| 58 | —CAPITAL SENIOR LIVING | 320,173 | $5.2B | 0.37% | |
| 59 | EVHEVOLENT HEALTH CLASS A | 307,800 | $4.6B | 0.32% | |
| 60 | BUWABIO RAD LABORATORIES CLASS A | 24,416 | $4.5B | 0.32% | |
| 61 | ALNYALNYLAM PHARMACEUTICALS | 118,475 | $4.4B | 0.32% | |
| 62 | —ABEONA THERAPEUTICS | 842,173 | $4.1B | 0.29% | |
| 63 | —PEREGRINE PHARMACEUTICALS INC 10.5 | 200,000 | $4.0B | 0.28% | |
| 64 | NVTA1EURINVITAE | 500,000 | $4.0B | 0.28% | |
| 65 | —PSIVIDA | 2,279,706 | $3.9B | 0.28% | |
| 66 | —ABEONA THERAPEUTICS CW-19 | 1,259,636 | $3.8B | 0.27% | |
| 67 | —AGILE THERAPEUTICS | 661,446 | $3.8B | 0.27% | |
| 68 | —ONCOBIOLOGICS | 1,248,990 | $3.8B | 0.27% | |
| 69 | ADMAADMA BIOLOGICS | 721,102 | $3.7B | 0.26% | |
| 70 | COLLCOLLEGIUM PHARMACEUTICAL | 196,728 | $3.1B | 0.22% | |
| 71 | CELGCELGENE | 26,000 | $3.0B | 0.21% | |
| 72 | —SYNERGY PHARMACEUTICALS | 490,300 | $3.0B | 0.21% | |
| 73 | —HISTOGENCIS CORP | 1,777,777 | $3.0B | 0.21% | |
| 74 | —MYOVANT SCIENCES | 226,322 | $2.8B | 0.20% | |
| 75 | —MGC DIAGNOSTICS | 329,733 | $2.6B | 0.19% | |
| 76 | —RA PHARMACEUTICALS | 165,000 | $2.5B | 0.18% | |
| 77 | SELBUSDSELECTA BIOSCIENCES | 141,875 | $2.4B | 0.17% | |
| 78 | —APTEVO THERAPEUTICS | 988,133 | $2.4B | 0.17% | |
| 79 | —CASCADIAN THERAPEUTICS | 546,498 | $2.4B | 0.17% | |
| 80 | ABTABBOTT LABORATORIES | 50,000 | $1.9B | 0.14% | |
| 81 | AERIEURAERIE PHARMACEUTICALS | 50,000 | $1.9B | 0.13% | |
| 82 | ATRCATRICURE | 94,400 | $1.8B | 0.13% | |
| 83 | CLDNEUREIGER BIOPHARMACEUTICALS | 157,679 | $1.8B | 0.13% | |
| 84 | PFEPFIZER | 55,000 | $1.8B | 0.13% | |
| 85 | —THERAPEUTICSMD | 300,000 | $1.7B | 0.12% | |
| 86 | —AVEO PHARMACEUTICALS | 3,108,808 | $1.7B | 0.12% | |
| 87 | —AEVI GENOMIC MEDICINE | 293,460 | $1.5B | 0.11% | |
| 88 | —AFFIMED | 734,301 | $1.3B | 0.09% | |
| 89 | ARWRARROWHEAD PHARMACEUTICALS | 847,458 | $1.3B | 0.09% | |
| 90 | —NEURODERM | 57,825 | $1.3B | 0.09% | |
| 91 | —ALLIQUA BIOMEDICAL | 1,921,951 | $1.1B | 0.08% | |
| 92 | —AZURRX BIOPHARMA | 227,272 | $1.1B | 0.08% | |
| 93 | —MEDICINES CO PUT 32 04/21/2017 | 200,000 | $1.1B | 0.08% | Put |
| 94 | —BARCLAYS BANK IPATH SandP 500 VIX SHORT TERM FUTURES ETN EXP | 41,000 | $1.0B | 0.07% | |
| 95 | BCLIEURBRAINSTORM CELL THERAPEUTICS | 400,000 | $1.0B | 0.07% | |
| 96 | CSBRCHAMPIONS ONCOLOGY | 372,597 | $942.0M | 0.07% | |
| 97 | —ARNO THERAPEUTICS INC | 4,177,577 | $781.0M | 0.06% | |
| 98 | —QUORUM HEALTH | 100,604 | $731.0M | 0.05% | |
| 99 | —ACCRETIVE HEALTH | 315,000 | $709.0M | 0.05% | |
| 100 | WCGEURWELLCARE HEALTHCARE PLANS | 5,056 | $693.0M | 0.05% |
Page 1 of 2Next